Drug Profile
Interferon-gamma - Sheffield
Alternative Names: IFN-gamma - SheffieldLatest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Sheffield Pharmaceuticals
- Class Antibacterials; Antineoplastics; Antivirals; Interferons; Lymphokines
- Mechanism of Action Cytokine stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory tract disorders
Most Recent Events
- 17 Jun 2003 Sheffield Pharmaceuticals has filed for protection under Chapter 7 bankruptcy laws
- 17 Jun 2003 Discontinued - Preclinical for Respiratory tract disorders in USA (Inhalation)
- 04 Oct 2001 Preclinical development for Respiratory tract disorders in USA (Inhalation)